Media and Communications

News

Earnings

Monday, October 06, 2014
Teva to Report Third Quarter 2014 Financial Results on October 30, 2014

JERUSALEM--(BUSINESS WIRE)--Oct. 6, 2014-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will release its third quarter 2014 financial results on Thursday, October 30, 2014 at 7:00 a.m. ET. Teva will host a conference call and live webcast on the same day, at 8:00 a.m. ET to discuss its third quarter 2014 results and overall business environment. A Question & Answer session will follow this discussion. In order to participate, please dial the following numbers (at least 10 minutes Read More »

Thursday, July 31, 2014
Teva Reports Second Quarter 2014 Results

Revenues of $5.0 billion, up 2% compared to the second quarter of 2013. Non GAAP operating income of $1.4 billion, an increase of 8%. GAAP operating income of $925 million. Non-GAAP net income of $1.05 billion, an increase of 4%. GAAP net income of $748 million. Non-GAAP diluted EPS of $1.23, an increase of 3%. GAAP diluted EPS of $0.87. Strong cash flow from operations of $1.25 billion, an increase of 43%, excluding the effect of payment rel Read More »

Friday, July 18, 2014
Teva to Report Second Quarter 2014 Financial Results on July 31, 2014

JERUSALEM--(BUSINESS WIRE)--Jul. 18, 2014-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that it will release its second quarter 2014 financial results on Thursday, July 31, 2014 at 7:00 a.m. ET. Teva will host a conference call and live webcast on the same day, at 8:00 a.m. ET to discuss its second quarter 2014 results and overall business environment. A Question & Answer session will follow this discussion. In order to participate, please dial the following numbers (at least 10 minutes b Read More »

Thursday, May 01, 2014
Teva Reports First Quarter 2014 Results

Revenues of $5.0 billion, up 2% compared to the first quarter of 2013. Non-GAAP net income of $1.0 billion, an increase of 8%. GAAP net income of $744 million, an increase of 18%. Non-GAAP diluted EPS of $1.22, an increase of 9%. GAAP diluted EPS of $0.87, an increase of 18%. Successful launch of Copaxone® 40mg/mL in the U.S.; on-track to achieve 30,000 patients on therapy by the end of May and 40,000 patients by the end of the year. U.S. gen Read More »

Thursday, March 20, 2014
Teva to Report First Quarter 2014 Financial Results on May 1, 2014

JERUSALEM--(BUSINESS WIRE)--Mar. 20, 2014-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will release its first quarter 2014 financial results on Thursday, May 1, 2014 at 7:00 a.m. ET. Teva will host a conference call and live webcast on the same day, at 8:00 a.m. ET to discuss its first quarter 2014 results and overall business environment. A Question & Answer session will follow this discussion. In order to participate, please dial the following numbers (at least 10 minutes befo Read More »

Thursday, December 19, 2013
Teva to Report Fourth Quarter 2013 Financial Results on February 6, 2014

JERUSALEM--(BUSINESS WIRE)--Dec. 19, 2013-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that it will release its fourth quarter 2013 financial results on Thursday, February 6, 2014 at 7:00 a.m. ET. Teva will host a conference call and live webcast on the same day, at 8:00 a.m. ET to discuss its fourth quarter 2013 results and overall business environment. A Question & Answer session will follow this discussion. In order to participate, please dial the following numbers (at least 10 minute Read More »

Thursday, October 31, 2013
Teva Reports Third Quarter 2013 Results

Net Revenues of $5.1 Billion Non-GAAP EPS of $1.27, GAAP Diluted EPS of $0.84 Full Year 2013 Net Revenues Expected to be Between $19.7 and $20.3 Billion;Non-GAAP Diluted EPS Expected to Be Between $4.95 -5.05 JERUSALEM--(BUSINESS WIRE)--Oct. 31, 2013-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today reported results for the quarter ended September 30, 2013. “Teva’s leadership and Board of Directors remain committed to executing on our strategy and diligentl Read More »

Thursday, October 10, 2013
Teva to Report Third Quarter 2013 Financial Results on October 31, 2013

JERUSALEM--(BUSINESS WIRE)--Oct. 10, 2013-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that it will release its third quarter 2013 financial results on Thursday, October 31, 2013 at 7:30 a.m. ET. Teva will host a conference call and live webcast on the same day, at 9:00 a.m. ET to discuss its third quarter 2013 results and overall business environment. A Question & Answer session will follow this discussion. In order to participate, please dial the following numbers (at least 10 minutes before the scheduled start time): United States and Canada 1-888-895-5271; Inte Read More »

Thursday, August 01, 2013
Teva Reports Second Quarter 2013 Results

Click here for WebcastNet Revenues of $4.9 Billion Non-GAAP Diluted EPS of $1.20, GAAP Diluted EPS Loss of $0.53 JERUSALEM--(BUSINESS WIRE)--Aug. 1, 2013-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today reported results for the quarter ended June 30, 2013. “Net revenue of $4.9 billion was in-line with the previous quarter, and we are pleased with increased sales in our Specialty franchise, as well as in our OTC business,” said Jeremy Levin, Teva’s President and Chief Executive Officer. “In the short to mid-term, we are especially excited by the positive momentum of our U.S. Gener Read More »

Thursday, May 02, 2013
Teva Reports First Quarter 2013 Results

Click here for Webcast Net Revenues Total $4.9 Billion Non-GAAP Diluted EPS of $1.12; GAAP Diluted EPS of $0.74 Cash Flow from Operations of $1.1 Billion JERUSALEM--(BUSINESS WIRE)--May. 2, 2013-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today reported results for the quarter ended March 31, 2013. “During the quarter, we were pleased by the overall performance of our specialty products and results of our OTC joint venture. Our generic operations, which are a core component of our business, performed in line with our expectations and were particularly strong in Western and East Read More »

​​​